Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-21

Clinical Trial Update: Bevacizumab Treatment and Retinal Vessel Monitoring

View source ↗

Summary

The clinical trial evaluating bevacizumab treatment with retinal vessel monitoring in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Cancer | Status: COMPLETED